-IANS The United States has asked the World Trade Organization (WTO) to rule on its assertion that India's restrictions on imports of US poultry meat and chicken eggs violates its WTO obligations. The US request to WTO to set up a dispute settlement panel was filed Monday after consultations with India on April 16-17, the first necessary step in pursuing a case, failed to resolve the US concerns, US Trade Representative (USTR)...

HETA, India – At the entrance to this village in India’s eastern state of Jharkhand, a large pond glistened under the bright autumn sun. Yellow and blue lilies surrounded it. A tailor was stitching clothes outside his shop while a few boys nearby were playing carrom on the lid of a rusted oil barrel. It was a tranquil, rustic setting – a candidate for a landscape painting, it seemed. But it...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...

In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat version of Bayer's patented anti-cancer drug, Nexavar, bringing down its price by 97%. In the first-ever case of compulsory licencing approval, the Indian Patent Office on Monday cleared the application of Hyderabad's Natco Pharma to sell generic drug Nexavar,...